MedPath
HSA Approval

PHYMORAX TABLET 10 mg

SIN09981P

PHYMORAX TABLET 10 mg

PHYMORAX TABLET 10 mg

September 8, 1998

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N05BB01

hydroxyzine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

MEDICA KOREA CO LTD

Active Ingredients

HYDROXYZINE HCl

10 mg

Hydroxyzine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PHYMORAX TABLET 10 mg - HSA Approval | MedPath